A critical role for B-vitamin nutrition in human developmental and evolutionary biology

Nutrition Research

Volumn 23, Issue 11, 2003, Pages 1463-1475

  Lucock, Mark ^b   Yates, Zoe ^a   Glanville, Tracey ^a   Leeming, Robert ^c   Simpson, Nigel ^a   Daskalakis, Ioannis ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B vitamins; Cobalamin; DNA; Folate; Homocysteine; Polymorphism

Indexed keywords

BIOPTERIN; COBALAMIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP;

CELL SURVIVAL; CPG ISLAND; DNA POLYMORPHISM; DNA STRAND BREAKAGE; ENERGY BALANCE; EVOLUTION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN GENOME; LANGUAGE DEVELOPMENT; METHYLATION; MOLECULAR MECHANICS; NUCLEOTIDE METABOLISM; NUTRIENT; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION; VITAMIN INTAKE;

EID: 0142025449     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(03)00156-8     Document Type: Article

References (62)

1. Friso S, Choi SW. Gene-nutrient interactions and DNA methylation. J Nutr 2002;132:2382S-2387S.
2. Fenesch M. Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDA). Food Chem Toxicol 2002;40:1113-17.
3. Hageman GJ, Stierum RH. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mut Res 2001;475:45-56.
4. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-38.
5. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van der Heuvel LP, Mariman ECM, den Heur M, Roger R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070.
6. Mills JL, Kirke PN, Molloy AM, Burke H, Conley MR, Lee J, Mayne PD, Weir DG, Scott JM. Methylenetetrahydrofolate reductase thermolabile variant and oral cleft. Am J Med Genet 1999;86:71-4.
7. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaynor DW. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down's syndrome. Am J Clin Nutr 1999;70:495-501.
8. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, Blomberg BM, Jakobs C, van Geijn HP. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-8.
9. Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol 1997;90:168-71.
10. Roberts D, Schwartz RS. Clotting and hemorrhage in the placenta-a delicate balance. N Engl J Med 2002;347:57-9.
11. Lucock MD, Yates Z. A differential role for folate in developmental disorders, vascular disease and other clinical conditions: The importance of folate status and genotype. In: Massaro EJ, editor. Folate and Human Development. Totowa, NJ: Humana Press, 2001. p. 263-298.
12. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers prevention 1999;8:513-8.
13. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interractions and risk of colorectal cancer. Cancer Res 1997;57:1098-102.
14. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999;96:12810-5.
15. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998;12:1491-97.
16. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomaki S, Airenne K, Janne J, Yla-Herttuala S. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 1999;19:2171-8.
17. Ying AK, Hassanain HH, Roos CM, Smiraglia DJ, Issa JJ, Michler RE, Caligiuri M, Plass C, Goldschmidt-Clermont PJ. Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc Res 2000;46:172-9.
18. Gu L, Wu J, Qiu L, Jennings CD, Li GM. Involvement of DNA mismatch repair in folate deficiency-induced apoptosis. J Nutr Biochem 2002;13:355-63.
19. Choi SW, Kim YI, Weitzel JM, Mason JB. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998;43:93-9.
20. 12 and serum total homocysteine levels in confirmed alzheimers disease. Arch Neurol 1998;55:1449-55.
21. Godfrey PSA, Toone BK, Carney MWP, Flynn T, Bottiglieri T, Laudy M, Chanarin I, Reynolds E. Enhacement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392-5.
22. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Coditz GA, Speizer FE, Willett WC. A prospective study of folate intake and the risk of breast cancer. JAMA 1999;281:1632-37.
23. Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 2001;153:680-7.
24. Kamei T, Kohono T, Ohwada H, Takeuchi Y, Hayashi Y, Fukuma S. Experimental study of the therapeutic effects of folate, vitamin A and vitamin B12 on squamous metaplasia of the bronchial epithelium. Cancer 1993;71:2477-83.
25. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers prevention 1999;8:513-8.
26. Butterworth CE. Folate status, women's health, pregnancy outcome and cancer. J Am Coll Nutr 1993;12:438-41.
27. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999;96:12810-5.
28. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 2002;77:491-8.
29. Perry IJ, Refsum H, Morris RW, Ebrabim SB, Ueland PM, Shaper AC. Prospective study of serum total homocysteine concentrations and risk of stroke in middle aged British men. Lancet 1995;346:1395-8.
30. Petri M, Roubenhoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systematic lupus erythematosus. Lancet. 1996;348:1120-24.
31. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial thickening and plasma homocysteine in asymptomatic adults: the atherosclerosis risk in communities study. Circulation 1993;87:1107-13.
32. Selhub J, Jacques PF, Boston AG. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
33. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
34. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000;72:315-23.
35. MRC Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
36. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down Syndrome. Am J Hum Genet 2000;67:623-30.
37. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig M. The structure and properties of methylenetetrahydrofolate reductase from E. coli suggest how folate ameliorates human hyperhomocysteinemia. Nature Structural Biology 1999;6:359-65.
38. Matthews RG. Cobalamin-dependent methyltransferases. Acc Chem Res 2001;34:681-9.
39. Oteanu H, Banerjee R. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 2001;276:35558-63.
40. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002;41:13378-85.
41. Yates Z, Lucock M. Methionine synthase polymorphism A2756G is associated with susceptibility for thromboembolic events and altered B vitamin/thiol metabolism. Haematologica 2002;87:751-56.
42. 12) increases risk for spina bifida. Molecular Genetics and Metabolism 1999;67:317-23.
43. Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI. Nonenzymatic degradation and salvage of dietary folate: Physicochemical factors likely to influence bioavailability. Biochemical and Molecular Medicine 1995;55:43-53.
44. Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 2001;74:172-85.
45. Lucock M, Yates Z, Hall K, Leeming R, Rylance G, MacDonald A, Green A. The impact of phenylketonuria on folate metabolism. Molecular Genetics and Metabolism 2002;76:305-12.
46. Smith I, Hyland K, Kendall B. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency. J Inherit Metab Dis 1985;8:39-45.
47. Jablonski NG, Chaplin G J. The evolution of human skin coloration. Hum Evol 2000;39:57-106.
48. Gambicher T, Bader A, Sauermann K, Altemeyer P, Hoffmann K. Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial. BMC Dermatol 2001;1(1):8.
49. Pennisi E. Evolution of developmental diversity. Evo-devo devotees eye ocular origins and more. Science 2002;296:1010-1.
50. Lucock M, Daskalakis I, Hinkins M, Yates Z. An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Molecular Genetics and Metabolism 2001;73:322-32.
51. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90.
52. Munoz-Moran E, Dieguez-Lucena JL, Femandez-Arcas N, Peran-Mesa S, Reyes-Engel A. Genetic selection and folate intake during pregnancy. Lancet 1998;352:1120-1.
53. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997;350:861.
54. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daures JP, Mares P. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost. 1999;81:891-9.
55. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF, Steegers-Theunissen RP, Eskes TK. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-5.
56. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002;70:758-62.
57. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000;151:862-77.
58. Hegele RA, Tully C, Young TK, Connelly PW. V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit. Lancet 1997;349:1221-2.
59. Pepe G, Camacho Vanegas O, Giusti B, Brunelli T, Marcucci R, Attanasio M, Rickards O, De Stefano GF, Prisco D, Gensini GF, Abbate R. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet 1998;63:917-20.
60. Rosenblatt DS, Whitehead VM. Cobalamin and folate deficiency: acquired and hereditary disorders in children. Semin Hematol 1999;36:19-34.
61. Eskes TK. Homocysteine and human reproduction. Clin Exp Obstet Gynecol 2000;27:157-67.
62. Rosenquist TH, Schneider AM, Monogham DT. N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. FASEB J 1999;13:1523-31.